[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100403069":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":22,"responsibleParty":44,"collaborators":7,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":55,"minAge":56,"maxAge":7,"enrollmentInfo":57,"targetDuration":7,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":7,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Genomic Prediction Inc.","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"OTHER","Preimplantation Genetic Testing","Embryo biopsies will undergo preimplantation genetic testing for aneuploidies as per standard of care, and polygenic disease risk (PGT-P) will be computed for these samples.",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Talia Metzgar, RN","CONTACT","(973) 529-4223","Talia@genomicprediction.com",{"name":20,"role":16,"phone":17,"phoneExt":7,"email":21},"Bhavini Rana","bhavini@genomicprediction.com",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Genomic Prediction Clinical Laboratory","RECRUITING","North Brunswick","New Jersey","08902","United States","US",{"type":32,"coordinates":33},"Point",[34,35],-74.482,40.454,{"lat":35,"lon":34},[38,40,41],{"name":15,"role":16,"phone":7,"phoneExt":7,"email":39},"talia@genomicprediction.com",{"name":20,"role":16,"phone":7,"phoneExt":7,"email":21},{"name":42,"role":43,"phone":7,"phoneExt":7,"email":7},"Nathan Treff, PhD","PRINCIPAL_INVESTIGATOR",{"type":45,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100403069","embryo-health-study-100403069",false,"NCT04528498","Embryo Health Study","The Embryo Health Study: Prospective Longitudinal Analysis of PGT-P","EHS","Inclusion Criteria:\n\n* All couples of Caucasian or East Asian ancestry above the age of 18 who elect to have PGT-A as part of their IVF treatment cycle.\n\nExclusion Criteria:\n\n* Any case where biological parental DNA is unavailable.\n* Any case involving PGT-M or PGT-SR.",true,"ALL","18 Years",{"count":58,"type":59},500,"ESTIMATED","OBSERVATIONAL","This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.",[63,64],"Infertility","Hereditary Diseases","2025-08-19",{"date":67,"type":68},"2025-08-26","ACTUAL",{"date":70,"type":68},"2020-12-01",{"date":72,"type":59},"2025-12-01",{"name":5,"class":6},1]